RPSA and Zika virus infectious disease: Moreover, our results showed that the intracellular region (1–85aa) of LAMR1 contributes to its binding to E protein and promotes E protein deubiquitination, suggesting that this region has the potential for use as a polypeptide drug for the treatment and prevention of ZIKV infection.